Lupus Trials News
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...Read More
November 12, 2019 Two positive clinical studies presented at the 2019 ACR/ARP Annual Meeting were conducted through the Lupus Clinical...Read More
November 8, 2019 Aurinia Pharmaceuticals announced results from a study showing that their investigational drug voclosporin did not significantly impact...Read More
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the Phase...Read More
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
NEW YORK, Nov. 10, 2019 /PRNewswire/ — The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by Genentech...Read More
Includes 16 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from two...Read More
October 28, 2019 Because lupus is hard to diagnose, many patients don’t get the treatments they need, while others get...Read More
October 17, 2019 A new study published in the European Journal of Neurology showed that epilepsy is significantly more common...Read More
October 7, 2019 A new study published in Annals of the Rheumatic Diseases found that among people with lupus, high...Read More
October 1, 2019 The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...Read More
September 26, 2019 In a newly published Michigan study, nearly 1 in 3 adults with systemic lupus erythematosus used prescription...Read More
September 19, 2019 A small clinical trial published in Lupus Science & Medicine found that taking vitamin D supplements did...Read More
September 18, 2019 The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...Read More
MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
NEW YORK, NY. August 29 — The Lupus Research Alliance is excited to share the good news that a potential...Read More
August 21, 2019 Newly published research found that belimumab (Benlysta®) effectively reduced the number of B cells, a type of...Read More
August 13, 2019 New research results showed that active Epstein-Barr virus increases the risk for lupus among relatives of people...Read More
August 8, 2019 In five pilot cities, people with lupus who are thinking about taking part in a clinical trial...Read More
July 30, 2019 Resolve Therapeutics announced that it has enrolled enough patients to conduct a Phase 2a study of a...Read More
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
New York, NY– June 27, 2019. The Lupus Research Alliance (LRA) and its affiliate, Lupus Therapeutics, announced that it has...Read More
June 25, 2019 Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus Therapeutics (LT) took part...Read More
June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...
March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...
February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....
An observational study published in Lupus of people with lupus found that of six factors, stress, depression and pain contributed most to...
A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...
Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA) announced that the first patient has been enrolled into a multiple-dose study...
A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...